Intralipid 10% and Liver function test abnormal - a phase IV clinical study of FDA data

Summary:

Liver function test abnormal is reported as a side effect among people who take Intralipid 10% (soybean oil), especially for people who are male, 2-9 old, have been taking the drug for 5 - 10 years also take Zantac, and have Short-bowel syndrome.

The phase IV clinical study analyzes which people have Liver function test abnormal when taking Intralipid 10%. It is created by eHealthMe based on reports of 229 people who have side effects when taking Intralipid 10% from the FDA, and is updated regularly.

What is Intralipid 10%?

Intralipid 10% has active ingredients of soybean oil. eHealthMe is studying from 229 Intralipid 10% users. Check the latest studies of Intralipid 10%.

What is Liver function test abnormal?

Liver function test abnormal is found to be associated with 1,502 drugs and 1,962 conditions by eHealthMe. Check the latest studies of Liver function test abnormal.

On Jul, 13, 2026

229 people reported to have side effects when taking Intralipid 10%.
Among them, 13 people (5.68%) have Liver function test abnormal.

Could Intralipid 10% cause Liver function test abnormal?

Among these 13 people:

How long have people been on Intralipid 10% when they have Liver function test abnormal? *

What is the gender of people who have Liver function test abnormal when taking Intralipid 10%? *

female: 15.38 %
male: 84.62 %

What is the age of people who have Liver function test abnormal when taking Intralipid 10%? *

What are other drugs people take besides Intralipid 10%? *

What are other side effects people have besides Liver function test abnormal? *

Hyperbilirubinaemia (excess of bilirubin in the blood): 7 people, 53.85%
Haemorrhage (bleeding): 4 people, 30.77%
Disseminated Intravascular Coagulation (systemic activation of blood coagulation): 4 people, 30.77%
Viral Infection: 3 people, 23.08%
Bilirubin Conjugated Increased: 3 people, 23.08%
Fever: 3 people, 23.08%
Cholestasis (a condition where bile cannot flow from the liver to the duodenum): 2 people, 15.38%
Jaundice - Yellow Skin (a yellowish pigmentation of the skin): 2 people, 15.38%
Intestinal Obstruction: 2 people, 15.38%
Blood Bilirubin Increased: 2 people, 15.38%

What are the existing conditions these people have? *

Short-Bowel Syndrome (a condition in which the body cannot absorb enough fluids and nutrients because part of the small intestine is missing): 4 people, 30.77%
Malabsorption (a state arising from abnormality in absorption of food nutrients across the gastrointestinal (gi) tract): 2 people, 15.38%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 2 people, 15.38%
Gastroschisis (a hole in the abdominal wall): 1 person, 7.69%
Gastrointestinal Perforation (hole in the digestive tract): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Intralipid 10% and have Liver function test abnormal?

- Check whether Liver function test abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Intralipid 10%:

Intralipid 10% (229 reports)

Browse all side effects of Intralipid 10%:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Liver function test abnormal:

Liver function test abnormal (1,502 drugs)

Browse all the conditions that are associated with Liver function test abnormal:

Liver function test abnormal (1,962 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on soybean oil (the active ingredients of Intralipid 10%) and Intralipid 10% (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.